A group-randomized evaluation of a quality improvement intervention to improve influenza vaccination rates in dialysis centers

Am J Kidney Dis. 2011 Feb;57(2):283-90. doi: 10.1053/j.ajkd.2010.09.019. Epub 2010 Dec 13.

Abstract

Background: Patients with end-stage renal disease (ESRD) are at high risk of complications from influenza, but many dialysis centers report <50% influenza immunization coverage.

Study design: A group-randomized evaluation of a multicomponent intervention to increase influenza vaccination rates in poorly performing dialysis centers in ESRD Networks 6, 11, and 15.

Setting & participants: Facilities with the lowest immunization percentages in 2006-2007 were selected from each network and randomly assigned to a standard (n = 39) or intensive intervention (n = 38).

Intervention: Standard intervention included a feedback report with comparison to other centers in their network and educational materials for staff and patients. Intensive-intervention centers also received 3 educational seminars, assistance with and review of center-specific action plans, and monthly monitoring of vaccination plan and rates.

Outcomes: Change in vaccination rate in following year.

Measurements: Dialysis center records of patient vaccination status.

Results: There was an 8.9% (P = 0.04) adjusted mean absolute difference in improvement between intensive- and standard-intervention centers.

Limitations: Some vaccinations were self-reported by patients. The vaccination data form does not have an option for patient data unavailable, which may have caused patients without data to be coded as unvaccinated.

Conclusions: Multicomponent interventions may serve as a successful strategy to increase influenza vaccination rates at poorly performing centers, with a benefit beyond that provided by usual oversight and support.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Female
  • Health Facilities*
  • Humans
  • Immunization Programs
  • Influenza Vaccines / therapeutic use*
  • Influenza, Human / prevention & control*
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Patient Education as Topic
  • Quality Assurance, Health Care*
  • Renal Dialysis*
  • Retrospective Studies

Substances

  • Influenza Vaccines